These findings are consistent with the known mechanism of action of SGLT2i, which improves diabetes by inhibiting renal glucose-sodium absorption, and show that residual insulin secretion was sufficient to inhibit ketogenesis, including in the presence of SGLT2i. This evidence concerns the gene INS and diabetes mellitus.